Cargando…
Reduced FBXW7 expression in pancreatic cancer correlates with poor prognosis and chemotherapeutic resistance via accumulation of MCL1
Pancreatic cancer is a highly malignant tumor type with poor outcomes, and elucidation of the mechanisms involved in cancer progression and therapeutic resistance is critical. FBXW7 is a key regulator of tumor malignant potential, and its substrate MCL1 regulates therapeutic resistance in human mali...
Autores principales: | Ishii, Norihiro, Araki, Kenichiro, Yokobori, Takehiko, Gantumur, Dorgormaa, Yamanaka, Takahiro, Altan, Bolag, Tsukagoshi, Mariko, Igarashi, Takamichi, Watanabe, Akira, Kubo, Norio, Hosouchi, Yasuo, Kuwano, Hiroyuki, Shirabe, Ken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762537/ https://www.ncbi.nlm.nih.gov/pubmed/29348852 http://dx.doi.org/10.18632/oncotarget.22634 |
Ejemplares similares
-
Poor prognosis in cholangiocarcinoma patients with low FBXW7 expression is improved by chemotherapy
por: Ishii, Norihiro, et al.
Publicado: (2017) -
Association of RAB5 overexpression in pancreatic cancer with cancer progression and poor prognosis via E-cadherin suppression
por: Igarashi, Takamichi, et al.
Publicado: (2017) -
Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins
por: Tsukagoshi, Mariko, et al.
Publicado: (2017) -
Conophylline suppresses pancreatic cancer desmoplasia and cancer‐promoting cytokines produced by cancer‐associated fibroblasts
por: Ishii, Norihiro, et al.
Publicado: (2018) -
Overexpression of natural killer group 2 member D ligands predicts favorable prognosis in cholangiocarcinoma
por: Tsukagoshi, Mariko, et al.
Publicado: (2016)